step semaglutide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Semaglutide for Weight Loss: What

A 2024 study found that GLP-1 drugs can likely be manufactured more cheaply than their current market costs of, for example, $95 in Brazil, $115 in South Africa, and $353 in the United States

What to Expect in 2025 and Beyond Todays GLP-1s are just the beginning of a major future factor influencing American health: behavior-supporting medication is in a renaissance, and investment in new medications and new indications is soaring

The weight management sector has faced problems for years with its assertions regarding the benefits of supplementation

Common Side Effects : Constipation, gas, and bloating

American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes 2026 Update